Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Price:
694.93
USD
-0.04%
Market Closed
Market Cap:
$72.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
US |
|
Safran SA
OTC:SAFRF
|
FR |
|
Richards Group Inc
TSX:RIC
|
CA |
|
R
|
Rli Corp
F:RL1
|
US |
|
Booz Allen Hamilton Holding Corp
NYSE:BAH
|
US |
|
K
|
Kraft Heinz Co
SWB:KHNZ
|
US |
|
U
|
US Bancorp
DUS:UB5
|
US |
|
CNS Pharmaceuticals Inc
NASDAQ:CNSP
|
US |
|
Stride Inc
NYSE:LRN
|
US |
|
S
|
Stroeer SE & Co KgaA
XMUN:SAX
|
DE |
|
K
|
Kraft Heinz Co
BMV:KHC
|
US |
|
C
|
Coloplast A/S
F:CBH
|
DK |
Multiples-Based Value
The Multiples-Based Value for Regeneron Pharmaceuticals Inc (REGN) under the Base Case is hidden
USD.
Compared with the current market price of 694.93 USD, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
REGN Multiples-Based Value
LOCKED
